Evidence map›Paper›PMID 41965414›Full record

ArticleScientific reports2026

Lightweight attention enhanced YOLOv11 for accurate multi class detection of brinjal diseases.

Athiraja A, Sujatha E, Gurulakshmi A B, Nagarajan S

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Athiraja ADepartment of CSE(CS), Saveetha Engineering College, Thandalam, Chennai, Tamilnadu, India.
Sujatha EDepartment of Computer Science and Engineering, Saveetha Engineering College, Thandalam, Chennai, Tamilnadu, India.
Gurulakshmi A BDepartment of Electronics and Communication Engineering, New Horizon College of Engineering, Bangalore, Karnataka, India.
Nagarajan SFaculty of Mechanical and Industrial Engineering, Bahir Dar Institute of Technology, Bahir Dar University, Bahir Dar, Ethiopia. drnagarajans@bdu.edu.et.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cultivation of brinjal is seriously affected by various pathogens which affect crop yield and quality hence the importance of automated disease detection systems in precision agriculture. The conventional image-based diagnostic methods fail to differentiate between similar diseases classes that look similar and this results in misdiagnosis and poor crop management. This research paper advances to suggest a lightweight deep learning model, IEMA-YOLOv11 (Improved Efficient Multi-Scale Attention-based YOLOv11), to successfully identify and detect Brinjal disease successfully in real-time. The model combines an EMA (Efficient Multi-Scale Attention) system, IRMB (Inverted Residual Mobile Blocks), and a LDFM (Local Detail Feature Module) to obtain fine-grained lesion features, as well as a refined MPDIoU loss to achieve a better object localization. The framework was tested against a curated multi-class brinjal disease data of six fungal, two bacterial, three viral and one nematode infection. IEMA-YOLOv11 had a precision of 96.5, a recall of 95.7, mAP@50 of 95.6 and mAP@50:95 of 94.9, with only 5.12M parameters and 17.1 GFLOPs. In comparison to the current benchmarks, IEMA-YOLOv11 was superior to YOLOv8-n by a margin of 2.4% in mAP@50, which has a potential to be used on a large scale to detect brinjal disease in a sustainable manner.

Indexed as

Deep LearningImage Processing, Computer-AssistedPlant DiseasesSolanum melongenaAnimalsDetection AlgorithmsBrinjal disease detectionDeep learning in agricultureEfficient multi-scale attention (EMA)Lightweight object detectionYOLOv11

Identifiers

PMID41965414
PMCPMC13230591

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.